Novel chalcone derivatives as hypoxia-inducible factor (HIF)-1 inhibitor: synthesis, anti-invasive and anti-angiogenic properties.
Clicks: 293
ID: 46797
2015
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Popular Article
30.0
/100
292 views
26 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
A novel series of chalcone derivatives were synthesized and their biological activities against HIF-1 were evaluated. Among these compounds, 5d exhibited clearly inhibitory effects on HIF-1 by downregulating the expression of HIF-1α under hypoxic conditions. Meanwhile, it also significantly suppressed VEGF-induced migration and invasion of Hep3B and HUVEC cells in nontoxic concentrations. Additionally, tube formation assay demonstrated its anti-angiogenesis activity. Moreover, the in vivo study indicated that compound 5d could retard tumor growth of Hep3B xenograft models and reduced CD31 and MMP-2 expression in tumor tissues. Finally, in acute intravenous toxicity, 5d was well tolerated and was found to be non-toxic up to 200 mg/kg in Swiss mice. These findings support the further investigation on the anti-invasive and anti-angiogenic potential of this class of compounds as HIF-1 inhibitor.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (130 words).
Try re-searching for a better abstract.
| Reference Key |
wang2015noveleuropean
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Wang, Lihui;Chen, Guoliang;Lu, Xiuhong;Wang, Shuang;Han, Shanghe;Li, Yi;Ping, Guanfang;Jiang, Xiaorui;Li, Huahuan;Yang, Jingyu;Wu, Chunfu; |
| Journal | European journal of medicinal chemistry |
| Year | 2015 |
| DOI |
10.1016/j.ejmech.2014.10.036
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.